Overview Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome Status: Completed Trial end date: 2008-01-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate if combination treatment with Bosentan and Sildenafil to patients with Eisenmenger syndrome is beneficial. Phase: Phase 3 Details Lead Sponsor: Rigshospitalet, DenmarkTreatments: BosentanSildenafil Citrate